Late last year, the chief leasing officer for Kilroy Realty Corp. saw more biotech companies showing interest in the second ...

A pharmaceutical packaging business that changed ownership last fall plans to close a St. Louis-area plant this spring, ...

Indian businesses have a significant presence in Mauritius, spanning financial services, IT, pharmaceuticals, and textiles. Mauritius is also among the largest sources of Foreign Direct Investment ...

Samuel S Chowdhury, chairman of Square Pharmaceuticals, yesterday expressed his willingness to purchase 15 lakh shares of the company, valued at over Tk 32 crore at the current market price.

New Jersey's pharmaceutical industry supports 370,000 jobs and generates $130 billion a year, or 20% of the state's economy. It already faced pushback in recent years from Democrats such as former ...

Square Pharmaceuticals – the country's leading drug manufacturer – has seen four of its directors collectively purchase 1.36 crore shares worth around Tk280 crore since 2020. The directors announced ...

Square Pharmaceuticals Managing Director Tapan Chowdhury has announced plans to purchase 15 lakh shares of the company, worth over Tk32 crore, from the secondary or block market within the next 30 ...

Merck, also known as MSD outside the U.S. and Canada, plans to significantly expand its workforce in India, aiming for around 2,700 employees by the year's end. The company focuses on therapy areas ...

The U.S. and its major trading partners have agreed to reciprocal tariff elimination for pharmaceutical products and chemicals used in drug production for the past 30 years, according to the U.S ...

However, I think aggressive growth investors might want to consider buying Madrigal Pharmaceuticals' shares. Some analysts project that Rezdiffra could generate peak annual sales of close to $3.5 ...

Shares of Madrigal Pharmaceuticals (NASDAQ: MDGL) were soaring 15.2% higher as of 11:05 a.m. ET on Wednesday. The big gain came after the small biopharmaceutical company announced its fourth ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...